Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Kestra Medical Technologies (KMTS) Accumulated Depreciation & Amortization (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Accumulated Depreciation & Amortization for 2 consecutive years, with $24.0 million as the latest value for Q2 2025.

  • On a quarterly basis, Accumulated Depreciation & Amortization rose 36.53% to $24.0 million in Q2 2025 year-over-year; TTM through Apr 2025 was $24.0 million, a 36.53% increase, with the full-year FY2025 number at $24.0 million, up 36.53% from a year prior.
  • Accumulated Depreciation & Amortization was $24.0 million for Q2 2025 at Kestra Medical Technologies, up from $17.5 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $24.0 million in Q2 2025 to a low of $17.5 million in Q2 2024.